Usefulness of Low-Dose Splenic Irradiation prior to Reduced-Intensity Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Elderly Patients with Myelofibrosis
The Janus kinase (JAK) 1 and 2 inhibitor, ruxolitinib, was recently approved in Japan and has been effective in many patients with myelofibrosis (MF). Although the inhibitor decreases splenomegaly and relieves MF-related symptoms, allogeneic hematopoietic cell transplantation (HCT) remains as the on...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Case Reports in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2016/8751329 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832558216749252608 |
|---|---|
| author | Etsuko Matsubara Jun Yamanouchi Riko Kitazawa Taichi Azuma Hiroshi Fujiwara Takaaki Hato Masaki Yasukawa |
| author_facet | Etsuko Matsubara Jun Yamanouchi Riko Kitazawa Taichi Azuma Hiroshi Fujiwara Takaaki Hato Masaki Yasukawa |
| author_sort | Etsuko Matsubara |
| collection | DOAJ |
| description | The Janus kinase (JAK) 1 and 2 inhibitor, ruxolitinib, was recently approved in Japan and has been effective in many patients with myelofibrosis (MF). Although the inhibitor decreases splenomegaly and relieves MF-related symptoms, allogeneic hematopoietic cell transplantation (HCT) remains as the only curative therapy for MF. The presence of splenomegaly has been reported as a risk factor for graft failure, delayed engraftment, and poor survival. Here, we report two elderly MF patients with massive splenomegaly and a JAK2 V617F mutation. These patients underwent splenic irradiation to decrease splenomegaly prior to HCT with a reduced-intensity conditioning (RIC) regimen. Massive splenomegaly gradually decreased by 4 Gy splenic irradiation. The subsequent RIC regimen involved 4 Gy total body irradiation and fludarabine and intravenous busulfan. In both patients, engraftment failure did not occur, and complete remission was achieved. The splenomegaly decreased, and MF-related symptoms were resolved. Furthermore, the JAK2 V617F mutation disappeared, and fibrosis in the bone marrow regressed. We suggest that splenic irradiation prior to the RIC regimen for HCT in elderly MF patients with massive splenomegaly is safe. Furthermore, the HCT protocols with splenic irradiation should be considered for patients who have not shown clinical benefits to optimal medical management such as treatment with ruxolitinib. |
| format | Article |
| id | doaj-art-fa2865350b48413192695692e777224c |
| institution | Kabale University |
| issn | 2090-6560 2090-6579 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Hematology |
| spelling | doaj-art-fa2865350b48413192695692e777224c2025-02-03T01:33:04ZengWileyCase Reports in Hematology2090-65602090-65792016-01-01201610.1155/2016/87513298751329Usefulness of Low-Dose Splenic Irradiation prior to Reduced-Intensity Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Elderly Patients with MyelofibrosisEtsuko Matsubara0Jun Yamanouchi1Riko Kitazawa2Taichi Azuma3Hiroshi Fujiwara4Takaaki Hato5Masaki Yasukawa6Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Toon, JapanDepartment of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Toon, JapanDepartment of Molecular Pathology, Ehime University Graduate School of Medicine, Toon, JapanDepartment of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Toon, JapanDepartment of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Toon, JapanDepartment of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Toon, JapanDepartment of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Toon, JapanThe Janus kinase (JAK) 1 and 2 inhibitor, ruxolitinib, was recently approved in Japan and has been effective in many patients with myelofibrosis (MF). Although the inhibitor decreases splenomegaly and relieves MF-related symptoms, allogeneic hematopoietic cell transplantation (HCT) remains as the only curative therapy for MF. The presence of splenomegaly has been reported as a risk factor for graft failure, delayed engraftment, and poor survival. Here, we report two elderly MF patients with massive splenomegaly and a JAK2 V617F mutation. These patients underwent splenic irradiation to decrease splenomegaly prior to HCT with a reduced-intensity conditioning (RIC) regimen. Massive splenomegaly gradually decreased by 4 Gy splenic irradiation. The subsequent RIC regimen involved 4 Gy total body irradiation and fludarabine and intravenous busulfan. In both patients, engraftment failure did not occur, and complete remission was achieved. The splenomegaly decreased, and MF-related symptoms were resolved. Furthermore, the JAK2 V617F mutation disappeared, and fibrosis in the bone marrow regressed. We suggest that splenic irradiation prior to the RIC regimen for HCT in elderly MF patients with massive splenomegaly is safe. Furthermore, the HCT protocols with splenic irradiation should be considered for patients who have not shown clinical benefits to optimal medical management such as treatment with ruxolitinib.http://dx.doi.org/10.1155/2016/8751329 |
| spellingShingle | Etsuko Matsubara Jun Yamanouchi Riko Kitazawa Taichi Azuma Hiroshi Fujiwara Takaaki Hato Masaki Yasukawa Usefulness of Low-Dose Splenic Irradiation prior to Reduced-Intensity Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Elderly Patients with Myelofibrosis Case Reports in Hematology |
| title | Usefulness of Low-Dose Splenic Irradiation prior to Reduced-Intensity Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Elderly Patients with Myelofibrosis |
| title_full | Usefulness of Low-Dose Splenic Irradiation prior to Reduced-Intensity Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Elderly Patients with Myelofibrosis |
| title_fullStr | Usefulness of Low-Dose Splenic Irradiation prior to Reduced-Intensity Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Elderly Patients with Myelofibrosis |
| title_full_unstemmed | Usefulness of Low-Dose Splenic Irradiation prior to Reduced-Intensity Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Elderly Patients with Myelofibrosis |
| title_short | Usefulness of Low-Dose Splenic Irradiation prior to Reduced-Intensity Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Elderly Patients with Myelofibrosis |
| title_sort | usefulness of low dose splenic irradiation prior to reduced intensity conditioning regimen for hematopoietic stem cell transplantation in elderly patients with myelofibrosis |
| url | http://dx.doi.org/10.1155/2016/8751329 |
| work_keys_str_mv | AT etsukomatsubara usefulnessoflowdosesplenicirradiationpriortoreducedintensityconditioningregimenforhematopoieticstemcelltransplantationinelderlypatientswithmyelofibrosis AT junyamanouchi usefulnessoflowdosesplenicirradiationpriortoreducedintensityconditioningregimenforhematopoieticstemcelltransplantationinelderlypatientswithmyelofibrosis AT rikokitazawa usefulnessoflowdosesplenicirradiationpriortoreducedintensityconditioningregimenforhematopoieticstemcelltransplantationinelderlypatientswithmyelofibrosis AT taichiazuma usefulnessoflowdosesplenicirradiationpriortoreducedintensityconditioningregimenforhematopoieticstemcelltransplantationinelderlypatientswithmyelofibrosis AT hiroshifujiwara usefulnessoflowdosesplenicirradiationpriortoreducedintensityconditioningregimenforhematopoieticstemcelltransplantationinelderlypatientswithmyelofibrosis AT takaakihato usefulnessoflowdosesplenicirradiationpriortoreducedintensityconditioningregimenforhematopoieticstemcelltransplantationinelderlypatientswithmyelofibrosis AT masakiyasukawa usefulnessoflowdosesplenicirradiationpriortoreducedintensityconditioningregimenforhematopoieticstemcelltransplantationinelderlypatientswithmyelofibrosis |